NeurAxis, Inc. (NRXS)
NeurAxis Market Cap : 78.26M for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.794B |
| Agenus, Inc. | 130.55M |
| Alnylam Pharmaceuticals, Inc. | 41.99B |
| Savara, Inc. | 1.162B |
| Arrowhead Pharmaceuticals, Inc. | 8.577B |
Market Cap Related Metrics
| PS Ratio | 17.89 |
| Price to Book Value | 23.05 |
| Price | 7.21 |
| Earnings Yield | -13.87% |